SCHEMBL19490296

SCHEMBL19490296

Cc1nc2ccccc2cc1Cc1c[nH]c2ccc(Br)cc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.61
SLC6A4 P31645 3/20 0.50
HTR2A P28223 2/20 0.46
TRPM8 Q7Z2W7 1/20 0.46
CSNK2A1 P68400 1/20 0.45
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44
PCSK9 Q8NBP7 1/20 0.44
HTR1A P08908 2/20 0.42
CCKBR P32239 2/20 0.42
ADRA2A P08913 1/20 0.42
DRD2 P14416 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
SLC6A2 P23975 1/20 0.42
ADRA1D P25100 1/20 0.42
HTR1D P28221 1/20 0.42
HTR1B P28222 1/20 0.42
HTR2C P28335 1/20 0.42
HTR1E P28566 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17775909 0.86 GPR84 (0.58) GPR84SLC6A4HTR2APCSK9HTR1A
SCHEMBL27929625 0.78 GPR84 (1.00) GPR84SLC6A4HTR2ATRPM8CSNK2A1
SCHEMBL31744805 0.78 GPR84 (0.73) GPR84SLC6A4HTR2ATRPM8CSNK2A1
SCHEMBL31744667 0.77 GPR84 (0.83) GPR84SLC6A4HTR2ATRPM8CSNK2A1
SCHEMBL31744782 0.77 GPR84 (0.71) GPR84SLC6A4HTR2ATRPM8CSNK2A1
SCHEMBL31744810 0.74 GPR84 (0.78) GPR84SLC6A4HTR2ATRPM8CSNK2A1
SCHEMBL31744842 0.73 GPR84 (0.76) GPR84SLC6A4HTR2ATRPM8CSNK2A1
SCHEMBL31744779 0.73 GPR84 (0.57) GPR84SLC6A4HTR2ATRPM8CSNK2A1
SCHEMBL28547448 0.73 GPR84 (0.75) GPR84SLC6A4HTR2ATRPM8CSNK2A1
SCHEMBL31744792 0.73 GPR84 (0.65) GPR84SLC6A4HTR2ATRPM8CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9795600-B2 Method for treating abnormal β-amyloid mediated diseases NATIONAL TAIWAN NORMAL UNIVERSITY (TW) 2017-10-24 US disclosed